Calcium phosphate cements for bone engineering and their biological properties

Bone repair remains a significant clinical challenge, especially for complex or large defects. Traditional approaches have limitations in terms of mechanical strength and biological integration. Researchers have explored various biomaterials to overcome these issues. Calcium phosphate cements (CPCs) have emerged as a promising option due to their similarity to the mineral component of bone. However, their full potential is yet to be realized. Early studies focused on mechanical and chemical stability, but recent efforts have shifted toward biological performance. This gap motivated the exploration of CPCs beyond structural support. That uncertainty drove the need to assess their role in tissue regeneration and cell interaction.

This review article aims to evaluate recent advancements in CPCs for bone engineering. The focus is on improving their biological properties to support tissue regeneration. The specific problem addressed is the need for CPCs to not only fill bone defects but also promote healing and integration. The motivation stems from the limitations of conventional CPCs in terms of osteoconductivity and osteoinductivity. The authors propose that new fabrication techniques and bioactive modifications can enhance CPC performance. This approach addresses the challenge of achieving functional bone regeneration. The study also considers how CPCs can be used to deliver cells and growth factors effectively. The ultimate goal is to guide future development of CPCs for clinical applications.

The authors conducted a comprehensive literature review to assess recent developments in CPCs. They focused on studies published in the last decade that explored CPC modifications. The review included in vitro and in vivo experiments on CPCs. Key areas of investigation were 3D printing, injectability, and bioactive additives. The researchers analyzed how these methods affect CPC performance. They compared traditional CPCs with newer formulations containing stem cells or growth factors. The review also examined co-culture and tri-culture techniques for pre-vascularization. The authors synthesized findings to evaluate the biological potential of CPCs.

Recent studies show that 3D printing improves the structural control of CPCs. Injectability allows for minimally invasive delivery of CPCs to bone defects. The addition of stem cells enhances osteogenic potential of CPC scaffolds. Growth factor incorporation supports cell differentiation and tissue formation. Pre-vascularization via co-culture techniques increases angiogenesis in CPCs. Tri-culture methods further improve vascular and bone formation outcomes. CPCs with bioactive additives show enhanced osteoconductivity and bioactivity. These findings suggest that CPCs can be tailored for specific tissue engineering applications.

The authors propose that CPCs can be optimized for bone tissue engineering through advanced fabrication and bioactive modification. They suggest that 3D printing and injectability improve clinical applicability. The use of stem cells and growth factors supports tissue regeneration. Co-culture and tri-culture techniques enhance vascularization and osteogenesis. CPCs with improved biological properties may offer better outcomes in bone repair. The findings suggest that CPCs can be tailored for specific clinical needs. The authors propose that further research is needed to validate these approaches in clinical settings. They suggest that CPCs have the potential to become a standard in bone tissue engineering.